Jump To Top

groundrushairsports

You are here:
Home / Posts Tagged "first-line"

first-line

U.S. Food and Drug Administration Approves Opdivo (nivolumab) in Combination with Cabometyx (cabozantinib) as First-line Treatment for Patients with Advanced Renal Cell Carcinoma

PRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every...

Researchers bioengineer first-line defense against COVID-19

Researchers at the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, the USC Institute for Technology and Medical Systems and the USC School of Pharmacy are developing an antimicrobial...